Dr. Channing Der and Dr. Adrienne Cox’s groundbreaking research on KRAS-targeted cancer therapies was featured in The New York Times article, “How an ‘Impossible’ Idea Led to a Pancreatic Cancer Breakthrough!”
Dr. Channing Der (L) and Dr. Adrienne Cox (R)
The May 12 article highlighted how their pioneering work at UNC helped establish KRAS mutations as key drivers of pancreatic cancer and laid the foundation for promising new treatments like daraxonrasib, an experimental drug showing encouraging results in patients with advanced pancreatic cancer.
Read the full The New York Times article, “How an ‘Impossible’ Idea Led to a Pancreatic Cancer Breakthrough.”